Eli Lilly (LLY) Return on Capital Employed [ROCE] (2009 - 2026)
Eli Lilly (LLY) posted Return on Capital Employed [ROCE] of 43.74% for Q3 2026, up 5.91 percentage points from 37.83% a year earlier but down 2.99 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Eli Lilly's Return on Capital Employed [ROCE] came in at 48.39%, up 10.75 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has increased for eight consecutive years, with a five-year change of +25.99 percentage points (FY2020 to FY2025).
- In prior years, Eli Lilly's Return on Capital Employed [ROCE] was 37.64% in FY2024 (+2.82 pp), 34.82% in FY2023 (+9.72 pp), 25.10% in FY2022 (+2.67 pp) and 22.43% in FY2021 (+0.03 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of 20.00% in Q1 2023 to a high of 46.74% in Q2 2026 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last 13 quarters, with an average year-over-year change of +6.93 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 10.02 percentage points; the weakest was Q2 2023, with a drop of 5.75 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 46.74% (Q2 2026), 42.94% (Q1 2026) and 37.22% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 17.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.41% |
| Jun 30, 2026 | 41.35% |
| Mar 31, 2026 | 40.51% |
| Dec 31, 2025 | 33.65% |
| Sep 30, 2025 | 34.52% |
| Jun 30, 2025 | 31.66% |
| Mar 31, 2025 | 26.76% |
| Dec 31, 2024 | 27.59% |
| Sep 30, 2024 | 42,238,151.48% |
| Jun 30, 2024 | 28,570,923.64% |
| Mar 31, 2024 | 11,967,121.64% |
| Dec 31, 2023 | 16,129,096.04% |
| Sep 30, 2023 | 3,593,609.75% |
| Jun 30, 2023 | 14,057,044.25% |
| Mar 31, 2023 | 31,581,622.14% |
| Dec 31, 2022 | 35,591,576.61% |
| Sep 30, 2022 | -17,007,694.31% |
| Jun 30, 2022 | 19.86% |
| Mar 31, 2022 | -14,926,595.46% |
| Dec 31, 2021 | -15,387,577.52% |
API Access
Eli Lilly Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();